JPMorgan Chase & Co. Has Lowered Expectations for IMAX (NYSE:IMAX) Stock Price

IMAX (NYSE:IMAX) had its price objective reduced by equities researchers at JPMorgan Chase & Co. from $48.00 to $47.00 in a research note issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 31.14% from the stock’s current price.

IMAX has been the topic of a number of other research reports. Seaport Research Partners raised their price objective on shares of IMAX from $43.00 to $45.00 and gave the stock a “buy” rating in a research note on Wednesday, April 8th. Wall Street Zen cut shares of IMAX from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 28th. Rosenblatt Securities reissued a “buy” rating and set a $47.00 price target on shares of IMAX in a report on Monday, April 20th. The Goldman Sachs Group lifted their price objective on shares of IMAX from $37.00 to $41.00 and gave the company a “neutral” rating in a report on Monday, March 2nd. Finally, Weiss Ratings downgraded shares of IMAX from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, April 24th. Nine equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $44.00.

IMAX Stock Down 5.7%

Shares of IMAX stock traded down $2.18 on Friday, hitting $35.84. The company had a trading volume of 2,350,746 shares, compared to its average volume of 1,104,589. The firm has a market cap of $1.97 billion, a P/E ratio of 57.80, a price-to-earnings-growth ratio of 1.68 and a beta of 0.41. The company has a 50-day moving average price of $38.22 and a 200-day moving average price of $36.42. IMAX has a twelve month low of $22.54 and a twelve month high of $43.16.

IMAX (NYSE:IMAX) last posted its earnings results on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.43 by $0.15. The firm had revenue of $125.21 million for the quarter, compared to analyst estimates of $120.30 million. IMAX had a return on equity of 13.53% and a net margin of 8.50%.IMAX’s revenue for the quarter was up 35.1% compared to the same quarter last year. During the same period last year, the company earned $0.27 earnings per share. Equities research analysts expect that IMAX will post 1.33 EPS for the current year.

Insider Transactions at IMAX

In other IMAX news, CEO Richard L. Gelfond sold 8,943 shares of the business’s stock in a transaction that occurred on Monday, April 27th. The stock was sold at an average price of $37.33, for a total transaction of $333,842.19. Following the completion of the sale, the chief executive officer directly owned 765,002 shares in the company, valued at approximately $28,557,524.66. The trade was a 1.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Kevin Douglas sold 330,200 shares of the stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $37.82, for a total value of $12,488,164.00. Following the transaction, the insider directly owned 3,657,450 shares of the company’s stock, valued at $138,324,759. The trade was a 8.28% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 1,054,284 shares of company stock valued at $40,062,532 in the last three months. Corporate insiders own 23.18% of the company’s stock.

Institutional Trading of IMAX

Several large investors have recently made changes to their positions in the company. Aurora Investment Counsel increased its position in IMAX by 0.4% during the third quarter. Aurora Investment Counsel now owns 70,235 shares of the company’s stock worth $2,300,000 after purchasing an additional 308 shares during the last quarter. Jones Financial Companies Lllp grew its stake in shares of IMAX by 43.8% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,041 shares of the company’s stock valued at $34,000 after buying an additional 317 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in shares of IMAX by 28.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,489 shares of the company’s stock worth $55,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC raised its position in shares of IMAX by 22.3% during the 4th quarter. GAMMA Investing LLC now owns 1,874 shares of the company’s stock valued at $69,000 after buying an additional 342 shares during the period. Finally, Arizona State Retirement System lifted its holdings in IMAX by 2.8% in the third quarter. Arizona State Retirement System now owns 13,517 shares of the company’s stock valued at $443,000 after acquiring an additional 364 shares during the last quarter. 93.51% of the stock is currently owned by hedge funds and other institutional investors.

Key IMAX News

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX expanded its theater footprint with Hoyts, adding a 10‑location rollout across Australia and New Zealand — strengthens international capacity and box‑office runway in ANZ. IMAX & HOYTS Expand Partnership To Rollout New Cinemas Across ANZ
• Positive Sentiment: Content tailwinds: IMAX cited hits like Project Hail Mary as a meaningful Q1 box‑office contributor, showing the company can still extract premium revenue from marquee titles. Imax Hails ‘Project Hail Mary’ For Q1 Boost Amid Tough Comparisons With Last Year’s ‘Ne Zha 2′ Bounty
• Positive Sentiment: Brand/PR wins: specialty programming (e.g., IMAX 70mm presentation of Apollo 11 in London) supports premium positioning and ancillary revenue potential. IMAX 70mm Version Of Apollo 11 Doc Now Showing At London Science Museum
• Neutral Sentiment: Q1 results were mixed: EPS beat at $0.17 (vs. $0.15 est.) and revenue slightly above estimates at $81.38M, but revenue was down ~6% YoY — a beat on the street but showing soft top‑line momentum. IMAX Corporation Reports First Quarter 2026 Results
• Neutral Sentiment: Investors can dig into the full Q1 call transcript for detail on regional trends, theatre installs and content cadence. IMAX Corporation (IMAX) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Insider sale: IMAX’s CEO sold about $333,842 of stock recently — a signal some investors interpret as a negative near‑term indicator. Insider Selling: IMAX (NYSE:IMAX) CEO Sells $333,842.19 in Stock
• Negative Sentiment: Press coverage emphasized that revenue and profit slipped despite big titles, reinforcing concerns over a tougher comps backdrop (last year’s Ne Zha 2) and near‑term top‑line pressure. Imax Q1 Revenue and Profit Decline Despite Hits Like ‘Avatar: Fire and Ash’ and ‘Project Hail Mary’

IMAX Company Profile

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.